SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosid who wrote (373)1/20/2000 3:08:00 PM
From: W Shakespeare  Read Replies (3) of 413
 
I find it interesting that LVCI and the other laser centers are getting killed along with VISX today. VISX procedures were flat for the quarter, but LVCI has been reporting very good procedure numbers. Investors still seem to believe that all the laser centers are exactly the same and will experience the same growth and pricing issues regardless of where their centers may be located. LVCI is located in smaller markets that may not react the same way that larger markets will to pricing issues. LVCI could still have substantial growth along with stable pricing.
I must further note that pricing pressures on VISX are not necessarily bad for LVCI. LVCI simply has more leverage with VISX in their purchase of new lasers.
Though my portfolio is extremely over weighted in the laser vision correction sector, I cannot help but buy more at these fire sale prices. The stocks are now discounted for a price war and a flattening of procedure numbers. It may take quite a while for the stock prices to recover, but I am prepared to wait it out. I can find no comparable place to get this kind of explosive growth at such an inexpensive price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext